QCM
HALO icon

Qsemble Capital Management’s Halozyme HALO Stock Holding History

Qsemble Capital Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,064
Closed -$974K – 471
2026
Q1 		$974K Buy
+15,064
New +$1.06M 0.07% 282
2025
Q4 		– Sell
-27,828
Closed -$2.04M – 537
2025
Q3 		$2.04M Buy
+27,828
New +$1.85M 0.2% 158
2025
Q1 		– Sell
-4,396
Closed -$210K – 496
2024
Q4 		$210K Buy
+4,396
New +$225K 0.03% 361

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Qsemble Capital Management's HALO Position: Q2 2026 in Review

Qsemble Capital Management sold out of Halozyme (HALO) in Q2 2026, closing a stake of 15,064 shares — an estimated $974K sold.

Qsemble Capital Management first reported a position in HALO in Q4 2024 and held it in 3 quarters. The position peaked at $2.04M in Q3 2025. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Qsemble Capital Management reported no remaining Halozyme position as of Q2 2026 after selling out during the quarter.
  • Qsemble Capital Management sold 15,064 Halozyme shares in Q2 2026, an estimated $974K.
  • Qsemble Capital Management first reported a position in Halozyme in Q4 2024 and held it in 3 quarters.
  • Qsemble Capital Management's Halozyme position peaked at $2.04M in Q3 2025.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Qsemble Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.